Management Team

The CHA team has direct, extensive experience in the biopharmaceutical industry. We bring together complementary skill sets and approach collaboration with the same degree of innovation we used in R&D. We have a deep understanding of the industry and a keen ability to see it objectively. Our clients include virtually all global biopharmaceutical companies, including the world's largest pharmaceutical companies.

	Ernest Bush, PhD Vice President & Research Director Dr. Ernie Bush, formerly with F. Hoffman-La Roche, is CHA's leader and expert in the area preclinical drug safety. Ernie serves as liaison and facilitator on CHA's multi-client, collaborative projects. Ernie has spent over 23 years working in the field of biomedical R&D most of which working in preclinical safety departments for major pharmaceutical companies. Read more
	Eric Glazer Vice President Eric Glazer has over fifteen years experience in marketing, e-marketing and lead generation, holding senior roles in various professional and information services companies. Throughout his career Eric has consulted professional services and IT companies on planning and implementing relationship marketing and lead generation programs to increase sales and brand recognition. Read more
	Jack Reynolds Special Advisor Jack recently retired from Pfizer after a total of almost 18 years with the Pfizer Global Research and Development division and over 30 years in the pharmaceutical industry. Over this time period he held numerous positions of increasing responsibility, and most recently was Senior Vice President of Research and Development and Worldwide Head of Safety Sciences and Comparative Medicine. Read more